Obeticholic acid may increase the risk of gallstone formation in susceptible patients.
Al-Dury S, Wahlström A, Panzitt K, Thorell A, Ståhlman M, Trauner M, Fickert P, Bäckhed F, Fändriks L, Wagner M, Marschall HU.
Al-Dury S, et al. Among authors: wahlstrom a.
J Hepatol. 2019 Nov;71(5):986-991. doi: 10.1016/j.jhep.2019.06.011. Epub 2019 Jun 27.
J Hepatol. 2019.
PMID: 31254596
Clinical Trial.